In neutrophils, intracellular Ca
2+ levels are regulated by several transporters and pathways, namely SERCA [sarco(endo)plasmic reticulum Ca
2+-ATPase], SOCE (store-operated calcium entry), and ROCE (receptor-operated calcium entry). However, the exact mechanisms involved in the communication among these transporters are still unclear.
[...] Read more.
In neutrophils, intracellular Ca
2+ levels are regulated by several transporters and pathways, namely SERCA [sarco(endo)plasmic reticulum Ca
2+-ATPase], SOCE (store-operated calcium entry), and ROCE (receptor-operated calcium entry). However, the exact mechanisms involved in the communication among these transporters are still unclear. In the present study, thapsigargin, an irreversible inhibitor of SERCA, and ML-9, a broadly used SOCE inhibitor, were applied in human neutrophils to better understand their effects on Ca
2+ pathways in these important cells of the immune system. The thapsigargin and ML-9 effects in the intracellular free Ca
2+ flux were evaluated in freshly isolated human neutrophils, using a microplate reader for monitoring fluorimetric kinetic readings. The obtained results corroborate the general thapsigargin-induced intracellular pattern of Ca
2+ fluctuation, but it was also observed a much more extended effect in time and a clear sustained increase of Ca
2+ levels due to its influx by SOCE. Moreover, it was obvious that ML-9 enhanced the thapsigargin-induced emptying of the internal stores. Indeed, ML-9 does not have this effect by itself, which indicates that, in neutrophils, thapsigargin does not act only on the influx by SOCE, but also by other Ca
2+ pathways, that, in the future, should be further explored.
Full article